3 recruiting, 2 completed, 1 active not recruiting, 1 withdrawn. 7 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Recruiting 3, Completed 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1 |
Follow Lymphoma, Primary Effusion: new trials by email Literature Review of Lymphoma, Primary Effusion trials Research Report on Lymphoma, Primary Effusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Recruiting | National Cancer Institute (NCI) | 15 | 2027-07-05 | 2026-11-05 |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) EB103 - B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins | Phase 1 / Phase 2 | Recruiting | Estrella Immunopharma, Inc. | 27 | 2024-06-01 | 2026-10-01 |
| Study of SGR-1505 in Mature B-Cell Neoplasms SGR-1505 - Mature B-Cell Neoplasm, Non Hodgkin Lymphoma | Phase 1 | Recruiting | Schrödinger, Inc. | 98 | 2023-04-10 | 2026-02-13 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 17 | 2017-07-03 | 2026-10-20 |
| Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies XmAb13676 - B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Xencor, Inc. | 154 | 2016-10-01 | 2024-11-13 |
| Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Pomalidomide, Rituximab, Prednisone - Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma | Phase 1 / Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2014-08-15 | 2018-08-31 | |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 107 | 2010-10-06 | 2023-11-21 |
Plasmablastic Lymphoma (4) · Lymphoma, B-Cell (3) · Lymphoma, Follicular (3) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Non-Hodgkin (3) · Burkitt Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Mantle-Cell (2) · Pyloric Stenosis, Hypertrophic (2) · Waldenstrom Macroglobulinemia (2) · HIV Infections (1) · Leukemia (1) · Leukemia, Hairy Cell (1)
Hemic and Lymphatic Diseases (7) · Immune System Diseases (7) · Immunoproliferative Disorders (7) · Lymphatic Diseases (7) · Lymphoproliferative Disorders (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Lymphoma (6) · Lymphoma, B-Cell (4) · Lymphoma, Non-Hodgkin (4) · Infections (3) · Virus Diseases (3) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Chronic Disease (2)
Cyclophosphamide (4) · Doxorubicin (4) · Prednisone (4) · Rituximab (4) · Vincristine (4) · Etoposide (3) · CT-P10 (2) · deltacortene (2) · prednylidene (2) · Biopsy (1) · Bronchoscopy (1) · Echocardiography (1) · Electrocardiography (1) · Endoscopy (1) · Lenalidomide (1)
National Cancer Institute (NCI) (4) · Estrella Immunopharma, Inc. (1) · Schrödinger, Inc. (1) · Xencor, Inc. (1)
United States (6) · France (2) · Italy (1) · Moldova (1) · Poland (1) · Romania (1) · South Korea (1) · Spain (1) · Ukraine (1) · United Kingdom (1)
Chet Bohac, PharmD, MD, MSc (1) · Frank G Basile, M.D. (1) · Juan C Ramos (1) · Pei Wang, PhD (1) · Ramya Ramaswami, MBBS, MPH (1) · Stefan K Barta (1) · Thomas S Uldrick, M.D. (1)
UM1CA121947 (2)